Biomarker: F283-IgE Oregano

Overview

Oregano is an aromatic herb obtained primarily from Origanum vulgare and related Origanum species. It belongs to the Lamiaceae, or mint, family and is used as a culinary herb, seasoning, and herbal product. Oregano-specific IgE may indicate sensitization associated with immediate allergic reactions, although clinically significant reactions appear uncommon and have mainly been described in case reports. Exposure commonly occurs through ingestion of seasoned foods, inhalation of herb particles, or occupational handling. Serum-specific IgE testing may help investigate suspected reactions, but a positive result indicates sensitization and does not by itself establish clinical allergy.

Clinical Use Cases

Evaluation of suspected IgE-mediated allergy: Helps assess sensitization when symptoms occur soon after eating or handling oregano, including oral symptoms, urticaria, angioedema, gastrointestinal symptoms, respiratory symptoms, or anaphylaxis.
Serum-specific IgE assessment: Measures IgE antibodies directed against oregano in a blood sample when oregano is suspected from the exposure history.
Investigation of exposure-related symptoms: Supports evaluation of reproducible symptoms associated with foods containing oregano, occupational handling, or inhalation of spice particles.
Integration with clinical history: Results should be interpreted with the timing, reproducibility, amount of exposure, symptom pattern, and other allergy-test findings. Specific IgE alone does not confirm that oregano caused the symptoms.
Assessment of related herb sensitization: Testing may be considered alongside evaluation for other Lamiaceae herbs, such as thyme, marjoram, basil, mint, or sage, when the clinical history suggests a broader sensitization pattern.
Confirmation of clinical relevance: When appropriate and medically supervised, controlled exposure or oral food challenge may be used to determine whether exposure produces symptoms. These procedures are not replaced by a positive blood test.

Specimen Types

Serum: Commonly used for measurement of oregano-specific IgE.
Blood: Venous blood is collected and processed to obtain serum for laboratory testing.

Measurement Methods

Allergen-specific IgE testing: In-vitro serum testing measures IgE antibodies that bind to oregano allergen extract. The result indicates immunologic sensitization and must be interpreted in the clinical context.
Quantitative immunoassay: Automated allergen-specific IgE platforms may report oregano-specific IgE as a concentration or class category. Assay thresholds and reporting systems may differ between platforms.
Component-resolved diagnostics: Individual oregano allergenic proteins are not sufficiently established for routine, clinically standardized component-resolved testing. Extract-based specific IgE testing is therefore the principal laboratory approach.
Additional clinical testing: Skin-prick or prick-to-prick testing with oregano may be used by an allergy specialist, but extract composition and test standardization can vary. Controlled oral exposure may be considered when the diagnosis remains uncertain.

Test Preparation and Influencing Factors

Fasting: Special fasting is generally not required for an allergy blood test.
Medications: Some medicines, including antihistamines, may affect certain allergy evaluations. Patients should report all medicines and supplements and should not stop treatment unless instructed by a healthcare professional.
Total IgE concentration: Markedly elevated total IgE may increase the likelihood of nonspecific or clinically irrelevant positive specific-IgE results. Total IgE should be considered when interpreting the result.
Sensitization versus clinical allergy: A detectable oregano-specific IgE result indicates sensitization, not necessarily symptomatic allergy. The result should be assessed against a compatible exposure history and symptoms.
Result magnitude: Higher specific-IgE concentrations may increase the likelihood of clinical reactivity in some settings, but the value does not reliably predict reaction severity and does not guarantee that symptoms will occur.
Age and clinical context: Interpretation should account for age, dietary exposure, atopic disease, other sensitizations, and the circumstances surrounding suspected reactions.
Cross-reactive sensitization: IgE binding to oregano may reflect sensitization to related Lamiaceae herbs or, in some patients, cross-reactive plant allergens. This may produce a positive result without clinically relevant reactions to every related plant.
Timing of collection: There is no established requirement to collect the sample immediately after an exposure. Testing is interpreted together with the clinical history and may be performed during or outside an active symptomatic episode.

Cross-Reactivity

Lamiaceae herbs: Human clinical evidence describes possible cross-sensitivity between oregano and related Lamiaceae herbs, including thyme, marjoram, basil, mint, sage, hyssop, and lavender. Evidence is limited and includes case-based in-vivo and in-vitro findings.
Oregano and thyme: A reported patient experienced systemic reactions after ingestion of oregano and thyme, with positive skin tests and serum-specific IgE to several Lamiaceae herbs. This supports possible cross-reactivity but does not establish that every oregano-sensitized person will react to thyme.
Pollen and herb sensitization: Studies of patients with birch, mugwort, or grass pollinosis have found increased sensitization to several culinary herbs, including oregano. Positive testing may therefore reflect pollen-associated or broader plant sensitization rather than clinically relevant oregano allergy.
Protein families: A single clinically validated oregano protein or component responsible for routine cross-reactivity has not been clearly established. Molecular component testing is not routinely available for oregano-specific clinical interpretation.
Clinical relevance: Immunologic cross-reactivity and a positive laboratory test do not necessarily correspond to symptoms after eating each related herb. Symptoms, exposure history, and, when indicated, supervised challenge remain important for determining clinical allergy.